Managing Successful Microbiological Investigations
Posted on October 17, 2013
By: Scott Smith, Quality Assurance Manager
G-Pharm
During this article I will give a proposal for some microbiological best practices that I have found to be practical, successful in resolving adverse events and received favourable comments in regulatory inspections. I will also compare and contrast microbiological investigations (MIR) with Analytic...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Analytical OOS, bioburden exceeding specification limits, CAPA implementation, cleanroom, endotoxin, FDA, G-Pharm, media fill positives, MHRA, Microbiological Investigations, microbiological investigations (MIR), microbiology
Related Products
Lonza’s QC Testing SolutionsSubscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
